SCHEMBL34281

SCHEMBL34281

CCN=C=NC(C)(N)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2997324 0.98
SCHEMBL14715713 0.80
Hydrochloric Acid SCHEMBL28751463 0.79
SCHEMBL531924 0.78
SCHEMBL6372816 0.77 CYP1A2 (0.30)
Hydrochloric Acid SCHEMBL28375754 0.76 CYP1A2 (0.34)
SCHEMBL19915260 0.75 CYP1A2 (0.31)
SCHEMBL3392050 0.74
SCHEMBL3778584 0.74
SCHEMBL8159853 0.73 CYP1A2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090043042-A1 Covalently Immobilized Fluorinated Carboxylic Acid Stationary Phase For Liquid Chromatography GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF COMMERCE, 2009-02-12 US claimed
US-20090017093-A1 GELATINOUS MATERIAL FOR FILLING BONE AND/OR CARTILAGE DEFECTS OSSACUR AG (DE) 2009-01-15 US claimed
EP-1046649-B1 Solid phase nucleic acid labeling by transamination ABBOTT MOLECULAR INC (US) 2006-06-28 EP claimed
US-20030166513-A1 Dds compound and process for the preparation thereof DAIICHI PHARMACEUTICALS CO., LTD. (JP) 2003-09-04 US claimed
EP-0175814-B1 PROCESS FOR PREPARING CEPHEM DERIVATIVES HAN-MI PHARMA IND. CO., LTD. (KR) 1990-05-23 EP claimed
US-4794170-A Method for the preparation of conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, the obtained conjugates and therapeutically active compositions containing them LABORATORI BALDACCI SPA (IT) 1988-12-27 US claimed
EP-0289110-A2 Conjugate malaria vaccine Swiss Serum and Vaccine Institute Berne (CH) 1988-11-02 EP claimed
EP-0184838-A2 Conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, a method for their preparation and therapeutically active compositions containing them LABORATORI BALDACCI Spa (IT) 1986-06-18 EP claimed
EP-0175814-A2 Process for preparing cephem derivatives HAN-MI PHARMA IND. CO., LTD. (KR) 1986-04-02 EP claimed
US-12571800-B2 Means and methods for treating angiogenesis-related diseases HEIDELBERG BIOTECH GMBH (DE) 2026-03-10 US disclosed
US-12552833-B2 Dynamics within supramolecuar IKVAV matrices enhance functional maturation of human IPSCS-derived neurons and regeneration NORTHWESTERN UNIVERSITY (US) 2026-02-17 US disclosed
US-20250255950-A1 PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING PASTEURELLA PROTEINS AND METHODS OF USE UIPCO, LLC 2025-08-14 US disclosed
WO-2025149619-A1 NANOPARTICLES COMPRISING AMPHIPHILIC POLYMERS AND LIPIDS FOR THE TARGETED DELIVERY OF ANTIGENS TOPAS THERAPEUTICS GMBH (DE) 2025-07-17 WO disclosed
US-12233120-B2 Proteins and immunizing compositions containing Pasteurella proteins and methods of use VAXXINOVA US, INC. (US) 2025-02-25 US disclosed
WO-1988009506-A1 ICE NUCLEATION IMMUNOASSAY ADVANCED GENETIC SCIENCES, INC. (US) 1988-12-01 WO disclosed
US-4784943-A ICE NUCLEATION BACTERIA AS LABELS ADVANCED GENETIC SCIENCES, INC. (US) 1988-11-15 US disclosed
EP-0289110-A2 Conjugate malaria vaccine Swiss Serum and Vaccine Institute Berne (CH) 1988-11-02 EP disclosed
US-4657873-A COATING WITH POLYPEPTIDE HENNING BERLIN GMBH (DE) 1987-04-14 US disclosed
US-4645646-A Luminescence immunoassay for haptens and chemiluminescence labelled hapten conjugates HENNING BERLIN GMBH CHEMIE-UND PHARMAWERK (DE) 1987-02-24 US disclosed
EP-0184838-A2 Conjugates of adenine-9-beta-arabinofuranoside 5' monophosphate with lactosaminated human albumin, a method for their preparation and therapeutically active compositions containing them LABORATORI BALDACCI Spa (IT) 1986-06-18 EP disclosed